絞り込み

16532

広告

Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).

著者 Kaneko Y , Kato M , Tanaka Y , Inoo M , Kobayashi-Haraoka H , Amano K , Miyata M , Murakawa Y , Yasuoka H , Hirata S , Tanaka E , Miyasaka N , Yamanaka H , Yamamoto K , Takeuchi T ,
Ann Rheum Dis.2018 May 31 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (16view , 0users)

Full Text Sources

Medical

Miscellaneous

To evaluate the sustained remission and low disease activity after discontinuation of tocilizumab in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate.
PMID: 29853455 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード